North Tide Capital’s Boston Scientific BSX Stock Holding History

North Tide Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,500,000	Closed	-$79.9M	–	25
2015 Q1	$79.9M	Sell	4,500,000 -500,000	-10%	-$7.9M	6.04%	6
2014 Q4	$66.3M	Hold	5,000,000	–	–	4.45%	9
2014 Q3	$59M	Hold	5,000,000	–	–	4.5%	10
2014 Q2	$63.9M	Buy	5,000,000 +3,400,000	+213%	+$44.2M	4.47%	9
2014 Q1	$21.6M	Sell	1,600,000 -2,400,000	-60%	-$31.5M	1.82%	17
2013 Q4	$48.1M	Sell	4,000,000 -600,000	-13%	-$7.09M	4.21%	12
2013 Q3	$54M	Sell	4,600,000 -400,000	-8%	-$4.33M	5.67%	4
2013 Q2	$46.4M	Buy	+5,000,000	New	+$42.4M	8.21%	3

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

North Tide Capital's BSX Position: Q2 2015 in Review

North Tide Capital sold out of Boston Scientific (BSX) in Q2 2015, closing a stake of 4,500,000 shares — an estimated $79.9M sold.

North Tide Capital first reported a position in BSX in Q2 2013 and held it in 8 quarters. The position peaked at $79.9M in Q1 2015. 470 funds tracked by Wall St. Rank hold BSX as of Q2 2015.

North Tide Capital reported no remaining Boston Scientific position as of Q2 2015 after selling out during the quarter.
North Tide Capital sold 4,500,000 Boston Scientific shares in Q2 2015, an estimated $79.9M.
North Tide Capital first reported a position in Boston Scientific in Q2 2013 and held it in 8 quarters.
North Tide Capital's Boston Scientific position peaked at $79.9M in Q1 2015.
470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2015.

Based on North Tide Capital's 13F filing for Q2 2015, filed 14 Aug 2015.